Hospitalizations due to the flu are the highest it’s been since 2018. Scientists don’t know why, and investors have yet to ...

Discover the best sectors for growth stocks in the next decade. Explore which sectors may present an opportunity to bolster ...

It wasn't so much the numbers from the final quarter of 2024 as it was management outlining the strategic changes it was ...

Alignment Healthcare has been on fire lately. In the past six months alone, the company’s stock price has rocketed 60.1%, reaching $13.88 per share. This performance may have investors wondering how ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ... as per exchange requirements. Change value during the period between ...

Healthcare isn't the hottest sector these days. While the S&P 500 has soared nearly 21% over the last 12 months, healthcare ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on CVS Health (CVS – Research Report) and ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Sanofi (SNYNF – Research Report) and Fate ...

A Leerink analyst says CVS is starting to benefit from stabilization in its Aetna health-insurance and pharmacy-benefits ...

Health-care companies rose, but not by as much as the broad market, as traders rotated into sectors more vulnerable to the effects of inflation and tariffs. Shares of GE HealthCare Technologies rose ...

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Biotech stocks are in the eye of the storm as the world recovers from the global pandemic. Government institutions and professional traders are banking on biotech stocks to continually develop a ...